Save information for later
Sign Up

Learn About Ependymoma

View Main Condition: Brain Tumor

What is the definition of Ependymoma?
An ependymoma is a type of tumor which mainly occurs in young children that affects the brain or spinal cord. Ependymomas arise from the ependymal cells lining the passageways where cerebrospinal fluid flows. Ependymomas are categorized by grades based on their characteristics: Grade I ependymomas are considered to be slow growing, low-grade tumors; Grade II ependymomas may occur in the brain or spine and are also considered to be low-grade tumors; Grade III ependymomas are malignant (cancer), fast-growing tumors that most often occur in the brain and sometimes the spine. Rarely, an ependymoma can occur in the ovaries.
What are the symptoms of Ependymoma?
The symptoms of an ependymoma depend on the area of the brain or spinal cord affected, and in the brain may include headaches, nausea and vomiting, or dizziness. In the spinal cord, an ependymoma may cause numbness and weakness in the arms, legs, or trunk and sexual, urinary, or bowel problems. Symptoms of an ependymoma in children may include headache and seizures. In adults, ependymoma more frequently occurs in the spinal cord, causing weakness in areas of the body controlled by spinal nerves affected by the tumor.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Ependymoma?
Treatment for an ependymoma is individualized, with the main treatment being surgical removal of the tumor. For tumors that cannot be treated with surgery or fully removed, radiosurgery, radiation therapy, or chemotherapy may be used.
Who are the top Ependymoma Local Doctors?

Northwestern Medical Faculty Foundation

10350 Haligus Rd, Suite A, 
Huntley, IL 
 8.3 mi
Accepting New Patients
Offers Telehealth

George Dephillips is a Neurosurgery provider in Huntley, Illinois. Dr. Dephillips and is rated as an Experienced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Subdural Hematoma, Chronic Subdural Hematoma, Delirium, Microdiscectomy, and Cervical Disc Surgery. Dr. Dephillips is currently accepting new patients.

Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Northwest Oncology And Hematology

27750 W. Hwy 22, Suite G70, Enter Medical Office Center 2, Turn Left Down Hallway. Office Is On The Right-hand Side., 
Barrington, IL 
 5.1 mi
Accepting New Patients
Offers Telehealth

Gary Gordon is a Hematologist Oncology specialist and a Hematologist in Barrington, Illinois. Dr. Gordon and is rated as an Experienced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Gallbladder Cancer, Gallbladder Adenocarcinoma, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Gordon is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Advocate Health And Hospitals Corporation

27750 W Hwy 22, 
Barrington, IL 
 6.7 mi

Jerry Liu is a Hematologist Oncology specialist and a Hematologist in Barrington, Illinois. Dr. Liu and is rated as an Advanced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.

What are the latest Ependymoma Clinical Trials?
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children with Recurrent Ependymoma

Summary: This study plans to detect the presence of trastuzumab by mass spectroscopy in relapsed posterior fossa ependymoma (PFEPN) tumor specimen pre-treated with a single dose of intrathecal (IT) trastuzumab, as well as to evaluate toxicity of intrathecal trastuzumab in combination with subcutaneous (subQ) Granulocyte-macrophage colony-stimulating factor (GM-CSF) in children with relapsed PFEPN

Match to trials
Find the right clinical trials for you in under a minute
Get started
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...